US Patent Issued to AUTOTAC on Sept. 30 for "P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,346, issued on Sept. 30, was assigned to AUTOTAC INC. (Seoul, South Korea).

"P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same" was invented by Yong Tae Kwon (Seoul, South Korea), Chang Hoon Ji (Seoul, South Korea), Srinivasrao Ganipisetti (Seoul, South Korea), Hee Yeon Kim (Seoul, South Korea), Su Ran Mun (Seoul, South Korea), Chan Hoon Jung (Seoul, South Korea), Eui Jung Jung (Seoul, South Korea) and Ki Woon Sung (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel p62 ligand compound, a stereoisomer, hydrate, solvate or prodrug ...